Literature DB >> 11231359

Effects of sodium artesunate, a new antimalarial drug, on renal function.

S B Campos1, L H Rouch, A C Seguro.   

Abstract

BACKGROUND: Sodium artesunate is currently used in malaria treatment. Adverse effects of this drug have not been described, probably because they cannot be differentiated from malaria-related effects.
METHODS: The effects on renal function of an acute infusion of sodium artesunate (12 mg/kg body weight) were studied in the rat with clearance techniques. We also evaluate the effect of sodium artesunate on chloride lumen-bath flux (Cl Jlb) in the isolated thick ascending limb of the loop of Henle (TALH) microperfused in vitro.
RESULTS: Acute infusion of artesunate to the rat decreased inulin clearance, despite an increase in renal blood flow. These effects were associated with an increase in urinary excretion of sodium, chloride, potassium, and nitric oxide metabolites (NO(2)/NO(3)). In water-loaded animals, artesunate increased sodium and water distal delivery and decreased free water clearance (C(H(2)O)) factored for sodium and water delivery. Following hypertonic NaCl infusion, artesunate decreased free water excretion (Tc(H(2)O)) corrected by clearance of osmolarity (C(Osm)). In vitro, artesunate 10(-6) and 10(-3) mol/L added to bath solution decreased chloride lumen-bath flux in isolated rabbit TALH in a dose-dependent manner, with the threshold effect at 10(-4) mol/L. This effect was completely blocked by N(G)-nitroL-arginine-metilester (L-NAME) 5 mmol/L. Artesunate 10(-4) mol/L added to the perfusion solution did not change Cl Jlb.
CONCLUSION: These findings suggest that artesunate decreases glomerular filtration rate and increases renal blood flow and urinary excretion of Na, Cl, and K. These effects were due, at least in part, to the inhibition of Cl transport across cortical and medullary TALH, and were mediated by local production of nitric oxide, since it is associated with an increase in NO(2)/NO(3) urinary excretion and it is blocked by L-NAME in vitro.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11231359     DOI: 10.1046/j.1523-1755.2001.0590031044.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

1.  Sodium artesunate-induced diuresis in a patient with malaria.

Authors:  Syed Ahmed Zaki; Preeti Shanbag; Vijay Lad; Prithi Shenoy
Journal:  Indian J Pharmacol       Date:  2011-07       Impact factor: 1.200

2.  Artesunate versus quinine in the treatment of severe imported malaria: comparative analysis of adverse events focussing on delayed haemolysis.

Authors:  Thierry Rolling; Dominic Wichmann; Stefan Schmiedel; Gerd D Burchard; Stefan Kluge; Jakob P Cramer
Journal:  Malar J       Date:  2013-07-15       Impact factor: 2.979

3.  Antimalarial drug and renal toxicity.

Authors:  Viroj Wiwanitkit
Journal:  J Nephropharmacol       Date:  2015-12-23

Review 4.  Enhancing the antimalarial activity of artesunate.

Authors:  J O Adebayo; H Tijjani; A P Adegunloye; A A Ishola; E A Balogun; S O Malomo
Journal:  Parasitol Res       Date:  2020-07-07       Impact factor: 2.289

5.  Mice rescued from severe malaria are protected against renal injury during a second kidney insult.

Authors:  Thiago P Abreu; Leandro S Silva; Christina M Takiya; Mariana C Souza; Maria G Henriques; Ana Acacia S Pinheiro; Celso Caruso-Neves
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

Review 6.  The Therapeutic Effect of Artemisinin and Its Derivatives in Kidney Disease.

Authors:  Ming Xia; Di Liu; Yu Liu; Hong Liu
Journal:  Front Pharmacol       Date:  2020-03-31       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.